Impact of Intensive Computerized Cognitive Training

Description

To investigate factors that predict cognitive enhancement following engagement in an intensive Computerized Cognitive Training Protocol.

Conditions

Acquired Brain Injury, Mild Cognitive Impairment, Mild Neurocognitive Disorder

Study Overview

Study Details

Study overview

To investigate factors that predict cognitive enhancement following engagement in an intensive Computerized Cognitive Training Protocol.

Computerized Cognitive Training: Characterization of Factors That Predict Cognitive Enhancement in Acquired Brain Injury

Impact of Intensive Computerized Cognitive Training

Condition
Acquired Brain Injury
Intervention / Treatment

-

Contacts and Locations

Boston

Brigham and Women's Hospital, Boston, Massachusetts, United States, 02115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient of the Mass General Brigham Health System with primary attention and executive functioning difficulties and/or a diagnosis of mild cognitive disorder or mild neurocognitive disorder (non-amnestic profile), due to an acquired brain injury (ABI) sustained at least 12 months prior to study contact.
  • * Ages 25-65 years old
  • * Proficiency in English
  • * Willing and able to complete all study-related activities for 12 months, including travel to Brigham and Women's Hospital (Boston) for four in-person assessment visits and two serum and saliva sample collections.
  • * Access to a computer with webcam and stable internet.
  • * A reliable study informant who can complete one questionnaire about participant's cognition/daily functioning, at four time points.
  • * History of alcohol or substance abuse, or dependence, within the past 2 years, as per DSM-5 criteria.
  • * High likelihood of an underlying progressive neurodegenerative disorder.
  • * Evidence of moderate to severe cognitive disorder, based on a score of 21 or less on the Mini-Mental Status Examination (MMSE) (Tombaugh \& McIntyre, 1992).
  • * Patient Health Questionnaire (PHQ)-9 (Kroenke et al., 2010) Score ≥ 19, unless deemed by treating provider not to have active depression (e.g., adjustment disorder, grief reaction).
  • * Active psychotic symptoms.
  • * Severe sensory losses such that participants would unlikely be able to participate in the study training, even with substantial accommodations (self-report of extreme difficulty reading ordinary newspaper print or a performance-tested corrected vision test score of worse than 20/30).
  • * Communication difficulties that prevent the participant from effectively participating in this highly interactive study protocol (based on interviewer's rating of a person's ability to be understood and to understand others).
  • * Current participation in a pharmacological, or other interventional research trial.
  • * Life expectancy of \< 2 years.

Ages Eligible for Study

25 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Brigham and Women's Hospital,

Kim C Willment, PhD, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital

Kirk R Daffner, MD, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital

Study Record Dates

2024-10-01